E-Leviate Pharma leverages proprietary, IP-protected technology to deliver cutting-edge solutions in drug delivery and biomedical innovation. The medical device from E-Leviate is designed to treat vaginal atrophy, genitourinary syndrome of menopause (GSM), pelvic organ prolapse (POP), urinary stress incontinence, and cystitis.
Why we invested
E-leviate is tackling a “silent epidemic” of menopause-associated disorders that disproportionately impacts Māori and Pacific women, who face cultural, systemic and access barriers to care. Its world-first estriol-eluting pessary ring combines structural support with six months of local oestrogen delivery, replacing messy daily creams and frequent clinical visits.
By reducing cost, complexity, and stigma in accessing treatment, E-leviate directly advances equity priorities and strengthens culturally safe, accessible support for women’s health.
Transaction Summary
IRIS+ is a set of generally-accepted system created by the Global Impact Investment Network (GIIN) to standardise impact metrics and themes.
Measuring What Matters
Menopause-associated disorders affect 30–55% of post-menopausal women, with 3–6% needing treatment, yet conditions remain a “silent epidemic”. Barriers are especially acute for Māori and Pacific women, due to a euro-centric care models.
Teacher’s Buddy is a digital platform that supports educators to plan, teach, and assess more efficiently. It reduces administrative work, improves teaching quality, and helps teachers provide more inclusive learning environments.
Teacher’s Buddy serves teachers and students across Aotearoa and is expanding internationally. It is designed for schools looking to improve teaching quality, support neurodiverse learners, and enhance inclusion.
Scale: Teacher’s Buddy has achieved strong traction in New Zealand and Australia and is scaling rapidly through a SaaS model that allows easy adoption by schools and teachers across multiple geographies.
Depth: Teachers using the platform report significant time savings and improved engagement with students. The platform provides targeted tools for inclusive education, helping teachers better support neurodiverse and differently-abled learners.
Duration: The impact is ongoing and cumulative. Each school year builds on prior results as teachers integrate the platform into daily practice.
Soul Capital’s investment enables Teacher’s Buddy to scale its platform, strengthen its impact framework, and reach more classrooms. Our capital helps embed equitable, evidence-based practices into the company’s growth and ensures impact is measured and improved as they expand into new markets.
Execution risk: Scaling quickly while maintaining user support and quality could be challenging, but the experienced founding team mitigates this.
Impacts of enterprises on people and the planet can be understood across five dimensions, as defined by the Impact Management Project.
